Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2011, Article ID 378041, 11 pages
http://dx.doi.org/10.4061/2011/378041
Review Article

Multimodality Imaging in the Evaluation of Cardiovascular Manifestations of Malignancy

1Department of Medical Imaging, University Health Network, Toronto, ON, Canada M5G 2C4
2Division of Cardiology, Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada M5G 2C4
3St. Michael’s Hospital, Department of Medical Imaging, Toronto, ON, Canada M58 1WB
4Department of Clinical Radiology, University of Munich Hospital, Ludwig Maximilians University, 80539 Munich, Germany
5Department of Medical Imaging, Toronto General Hospital, 585 University Avenue, Toronto, ON, Canada M5G 2C4

Received 12 October 2010; Accepted 3 January 2011

Academic Editor: Syed Wamique Yusuf

Copyright © 2011 Laura Jiménez-Juan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. Klein and J. P. Thirion, “Cardiovascular imaging to quantify the evolution of cardiac diseases in clinical development,” Biomarkers, vol. 10, supplement 1, pp. S1–S9, 2005. View at Google Scholar · View at Scopus
  2. S. V. Del Castillo, R. Aguilar Torres, and J. C. Paré Bardera, “Update on cardiac imaging techniques: echocardiography, cardiac magnetic resonance, and multidetector computed tomography,” Revista Espanola de Cardiologia, vol. 62, supplement 1, pp. 129–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. S. Douglas, B. Khandheria, R. F. Stainback et al., “ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography,” Journal of the American College of Cardiology, vol. 50, no. 2, pp. 187–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Rao, N. Sajnani, L. L. Kusnetzky, and M. L. Main, “Appropriate use of transthoracic echocardiography,” American Journal of Cardiology, vol. 105, no. 11, pp. 1640–1642, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. O. Bonow, B. A. Carabello, K. Chatterjee et al., “ACC/AHA 2006 guidelines for the management of patients with valvular heart disease,” Journal of the American College of Cardiology, vol. 48, no. 3, pp. e1–e148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. E. A. Tee and P. M. Shah, “Transesophageal echocardiography,” Journal of Intensive Care Medicine, vol. 7, no. 3, pp. 113–126, 1992. View at Google Scholar · View at Scopus
  7. J. D. Thomas and Z. B. Popović, “Assessment of left ventricular function by cardiac ultrasound,” Journal of the American College of Cardiology, vol. 48, no. 10, pp. 2012–2025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Hare, J. K. Brown, R. Leano, C. Jenkins, N. Woodward, and T. H. Marwick, “Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab,” The American Heart Journal, vol. 158, no. 2, pp. 294–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. T. H. Marwick, “Echocardiography in the era of multimodality imaging,” Heart Lung and Circulation, vol. 19, no. 3, pp. 175–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. U. J. Schoepf, C. R. Becket, L. K. Hofmann, and E. K. Yucel, “Multidetector-row CT of the heart,” Radiologic Clinics of North America, vol. 41, no. 3, pp. 491–505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. McCullough, A. Adam, C. R. Becker et al., “Risk prediction of contrast-induced nephropathy,” American Journal of Cardiology, vol. 98, no. 6A, pp. 27K–36K, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Lameire, A. Adam, C. R. Becker et al., “Baseline renal function screening,” American Journal of Cardiology, vol. 98, no. 6A, pp. 21K–26K, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Bastarrika, Y. S. Lee, W. Huda, B. Ruzsics, P. Costello, and U. J. Schoepf, “CT of coronary artery disease,” Radiology, vol. 253, no. 2, pp. 317–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. E. L. Nickoloff and P. O. Alderson, “A comparative study of thoracic radiation doses from 64-slice cardiac CT,” British Journal of Radiology, vol. 80, no. 955, pp. 537–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. H. O'Donnell, S. Abbara, V. Chaithiraphan et al., “Cardiac tumors: optimal cardiac MR sequences and spectrum of imaging appearances,” American Journal of Roentgenology, vol. 193, no. 2, pp. 377–387, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Hoffmann, S. Von Bardeleben, F. ten Cate et al., “Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography,” European Heart Journal, vol. 26, no. 6, pp. 607–616, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Francis and D. J. Pennell, “Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation,” Journal of Cardiovascular Magnetic Resonance, vol. 2, no. 2, pp. 139–141, 2000. View at Google Scholar · View at Scopus
  18. S. C. Port and F. J. Wackers, “Clinical application of radionuclide angiography,” Journal of Nuclear Cardiology, vol. 2, no. 6, pp. 551–558, 1995. View at Google Scholar · View at Scopus
  19. M. J. Aiken, V. Suhag, C. A. Garcia et al., “Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging,” Clinical Nuclear Medicine, vol. 34, no. 11, pp. 762–767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. J. Klocke, M. G. Baird, B. H. Lorell et al., “ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary,” Journal of the American College of Cardiology, vol. 42, no. 7, pp. 1318–1333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Butany, V. Nair, A. Naseemuddin, G. M. Nair, C. Catton, and T. Yau, “Cardiac tumours: diagnosis and management,” Lancet Oncology, vol. 6, no. 4, pp. 219–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Gaudio, G. Tanzilli, P. Mazzarotto et al., “Comparison of left ventricular ejection fraction by magnetic resonance imaging and radionuclide ventriculography in idiopathic dilated cardiomyopathy,” American Journal of Cardiology, vol. 67, no. 5, pp. 411–415, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. J. O. Wee, J. D. Sepic, T. Mihaljevic, and L. H. Cohn, “Metastatic carcinoid tumor of the heart,” Annals of Thoracic Surgery, vol. 76, no. 5, pp. 1721–1722, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Chiles, P. K. Woodard, F. R. Gutierrez, and K. M. Link, “Metastatic involvement of the heart and pericardium: CT and MR imaging,” Radiographics, vol. 21, no. 2, pp. 439–449, 2001. View at Google Scholar · View at Scopus
  25. D. V. Miller and H. D. Tazelaar, “Cardiovascular pseudoneoplasms,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 3, pp. 362–368, 2010. View at Google Scholar · View at Scopus
  26. N. Mansencal, L. Revault-d'Allonnes, J. P. Pelage, J. C. Farcot, P. Lacombe, and O. Dubourg, “Usefulness of contrast echocardiography for assessment of intracardiac masses,” Archives of Cardiovascular Diseases, vol. 102, no. 3, pp. 177–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Trifunovic, B. Vujisic-Tesic, M. Vuckovic et al., “Multimodality imaging in the assessment of cardiac lymphoma presented as new-onset atrial fibrillation,” Echocardiography, vol. 27, no. 3, pp. 332–336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Higgings and A. De Ross, MRI and CT of the Cardiovascular System, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2005.
  29. J. Barkhausen, P. Hunold, H. Eggebrecht et al., “Detection and characterization of intracardiac thrombi on MR imaging,” American Journal of Roentgenology, vol. 179, no. 6, pp. 1539–1544, 2002. View at Google Scholar · View at Scopus
  30. M. B. Srichai, C. Junor, L. L. Rodriguez et al., “Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation,” American Heart Journal, vol. 152, no. 1, pp. 75–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Tatli and M. J. Lipton, “CT for intracardiac thrombi and tumors,” International Journal of Cardiovascular Imaging, vol. 21, no. 1, pp. 115–131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. P. A. N. Chandraratna, “Echocardiography and doppler ultrasound in the evaluation of pericardial disease,” Circulation, vol. 84, supplement 3, pp. I303–I310, 1991. View at Google Scholar · View at Scopus
  33. R. Rienmüller, R. Gröll, and M. J. Lipton, “CT and MR imaging of pericardial disease,” Radiologic Clinics of North America, vol. 42, no. 3, pp. 587–601, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. R. Carver, C. L. Shapiro, A. Ng et al., “American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects,” Journal of Clinical Oncology, vol. 25, no. 25, pp. 3991–4008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. W. O. Ntim and W. G. Hundley, “Imaging surveillance for cardiovascular complications of cancer therapy,” Journal of the American College of Cardiology, vol. 55, no. 2, pp. 171–172, 2010. View at Publisher · View at Google Scholar
  36. W. Machann, M. Beer, M. Breunig et al., “Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for hodgkin's disease,” International Journal of Radiation Oncology, Biology, Physics, vol. 79, no. 4, pp. 1117–1123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. C. Hull, C. G. Morris, C. J. Pepine, and N. P. Mendenhall, “Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy,” Journal of the American Medical Association, vol. 290, no. 21, pp. 2831–2837, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Malanca, C. Cimadevilla, E. Brochet, B. Iung, A. Vahanian, and D. Messika-Zeitoun, “Radiotherapy-induced mitral stenosis: a three-dimensional perspective,” Journal of the American Society of Echocardiography, vol. 23, no. 1, pp. 108.e1–108.e2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. R. D. Perel, R. E. Slaughter, and W. E. Strugnell, “Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma,” Journal of Cardiovascular Magnetic Resonance, vol. 8, no. 6, pp. 789–791, 2006. View at Publisher · View at Google Scholar · View at Scopus